# YD Bio Limited (YDES) fundamentals

Data as of 2026-09-09. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $4.25, market value $301 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). YD Bio Limited reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 504.4×**. Each dollar of revenue is priced at 504.4×, a level that requires very high margins or very fast growth to justify.
- **Free-cash-flow yield: -2.7%** (5-yr avg -1.0%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 28.1%**. YD Bio Limited keeps 28.1% of revenue after the direct cost of what it sells.
- **Operating margin: -883.3%**. Operating margin is negative: the business loses money before interest and tax.
- **Return on equity: 291.0%**. A 291.0% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: 47.0%**. Return on all capital, debt included, is 47.0%: comfortably above what that capital costs.
- **Return on assets: -60.3%**. Each dollar of assets produces -60.3% of profit.

## Growth
- **Revenue growth (1 yr): 16.9%**. Revenue grew 16.9% over the last year.
- **EPS growth (1 yr): -500.0%**. Earnings per share fell 500.0%, slower than revenue, so margins compressed.

## Financial health
- **Current ratio: 5.88** (quick 5.88). Current assets cover the next year's liabilities 5.88 times.
- **Altman Z-score: 10.05**. A Z-score of 10.05 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. YD Bio Limited does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -76.0%** (YTD -71.0%, 3-mo 17.6%). The shares are down 76.0% over twelve months including dividends.
- **From 52-week high: -83.0%** (150.0% above the low). Trading 83% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 50**. An RSI of 50 is neutral.
- **Beta (1 yr): -0.13** (volatility 123%). Beta of -0.13 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=YDES · Page: https://foliofundamentals.com/stocks/ydes

Not investment advice.